The National Institute of Neurological Disorders and Stroke (NINDS) is offering the NeuroNEXT Small Business Innovation in Clinical Trials (U44) grant. This funding opportunity is specifically designed to encourage small businesses to undertake exploratory clinical trials. These trials should investigate new agents, including drugs, biologics, surgical therapies, or medical devices, aiming to address neurological disorders. The core purpose of this grant is to generate preliminary data and strong justification necessary for the development and design of larger, more comprehensive clinical studies in the future. Proposed research must align with NINDS’s strategic plan and clinical research priorities, ensuring that the work contributes to advancing treatments for significant neurological conditions.
Opportunity ID: 294374
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-17-300 |
| Funding Opportunity Title: | NeuroNEXT Small Business Innovation in Clinical Trials (U44) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 05, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jan 05, 2018 |
| Current Closing Date for Applications: | Jan 05, 2018 |
| Archive Date: | Feb 10, 2018 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS’ strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm ). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-17-300.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00232967 | Aug 05, 2017 | Jan 05, 2018 | View |
Package 1
Mandatory forms
294374 RR_SF424_2_0-2.0.pdf
294374 PHS398_CoverPageSupplement_3_0-3.0.pdf
294374 RR_OtherProjectInfo_1_3-1.3.pdf
294374 PerformanceSite_2_0-2.0.pdf
294374 RR_KeyPersonExpanded_2_0-2.0.pdf
294374 RR_Budget_1_3-1.3.pdf
294374 PHS398_ResearchPlan_3_0-3.0.pdf
294374 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
294374 RR_SubawardBudget30_1_3-1.3.pdf
294374 PHS_Inclusion_Enrollment_Report-1.0.pdf
294374 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
